Back to Rare Disease
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05211648

NCT05211648
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are fluent in English, both reading and speaking
  • You are already enrolled in the Remote Hypertension Program
  • Your blood pressure readings have been above 140/90 on average across your last 3 clinic visits in the past 18 months, OR your most recent clinic blood pressure was above 140/90 in the last 6 months, OR your doctor referred you and your last blood pressure reading was above 130/80
  • You own an iPhone

Who may not be able to join:

  • Your resting heart rate is faster than 120 beats per minute
  • You have a persistent irregular heart rhythm called atrial fibrillation
  • You have severe heart failure where the heart is pumping at very low capacity (confirm with trial site)
  • You have a rare adrenal gland tumour called pheochromocytoma
  • You have Raynaud's disease, a condition affecting blood flow to the fingers and toes
  • You experience ongoing trembling or shivering
  • You are currently pregnant
  • You are currently breastfeeding
  • You have a surgically created connection between an artery and vein, such as for dialysis (confirm with trial site)
  • You have had an arm amputation
  • You have a skin condition that causes widespread skin shedding (confirm with trial site)
  • You have lymphoedema, which is swelling caused by a problem with the lymphatic system
  • You have a known allergy to silicone
  • You do not live in Massachusetts
  • Your last visit to a Mass General Brigham (MGB) clinic was more than 3 years ago
  • Your doctor is not part of the Mass General Brigham (MGB) healthcare system
  • You have a terminal medical condition
  • You have advanced kidney disease with significantly reduced kidney function (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Aktiia SA
Registry
clinicaltrials_gov
Start date
10 February 2022
Est. completion
23 May 2023

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Diastolic and Systolic Pressures differences between weekly Diastolic and Systolic pressures averages provided by Home Blood Pressure Monitoring and by Aktiia 24h data.; Diastolic and Systolic Pressures differences between monthly Diastolic and Systolic pressures averages provided by Home Blood Pressure Monitoring and by Aktiia 24h data.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov